Hyperactive AID/APOBEC and hmC dominant TET enzymes
AssigneeThe Trustees of the University of Pennsylvania
InventorsRahul Kohli, Emily Schutsky, Monica Yun Liu
Life of this patent
Estimating the term…
Abstract
The present invention includes mutant AID, APOBEC, and Tet enzymes with improved functions. In one aspect the invention provides APOBEC fusion proteins comprising hyperactive deamination activity. In another aspect, the invention provides AID mutant proteins comprising hyperactive deamination activity. In yet another aspect, the invention provides mutant Tet proteins capable of stalling oxidation at a 5-hydroxymethylcytosine (hmC).
Claims2
A fusion protein comprising deamination activity comprising a first domain and a second domain, wherein the first domain comprises an apolipoprotein B editing complex (APOBEC) 3B (A3B) domain and the second domain comprises an APOBEC3A (A3A) catalytic domain, said fusion protein comprising SEQ ID NO:
- 8 and exhibiting deamination activity that is greater than that of either A3B or A3A alone.
A mutant A3B protein of SEQ ID NO:
- 3, wherein the mutant A3B sequence mutations in SEQ ID NO:
- 3 consist of D196H, T197I, Delta(206-210), Ins(206)GIG, R212H Q213K, W228S 1230K, M235R, C239H, E241Q, E342K, Y343H, Y350D, R351H, and E363D, wherein the mutant A3B protein displays deamination activity that is greater than A3B.
Dependencies are inferred from the claim text.